Dosage and administration
Type C medicated feeds containing SAFE-GUARD ® 20% can be fed in either a mash or pelleted form. No prior withdrawal of feed or water is necessary.
Safe-Guard
- Manufacturer
- Merck Sharp & Dohme Corp. | ADM Alliance Nutrition, Inc.
- Effective date
- 2024-11-19
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 02:43:54
Label at a glance#
ProductSafe-Guard
Active ingredientFENBENDAZOLE
Label structure31 sections
Storage and handling
STORE AT OR BELOW 25°C (77°F). EXCURSIONS UP TO 40°C (104°F) ARE PERMITTED.
Contacts and useful links#
Websitewww.fda.gov
www.fda.gov/reportanimalae
www.fda.gov/reportanimalaeLabel contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
CATTLE: Dairy and Beef Cattle
SWINE: Growing pigs, gilts, pregnant sows and boars
HORSES
Zoo and Wildlife Animals
Growing Turkeys
Wild Quail
MUST BE MIXED BEFORE FEEDING ACCORDING TO DIRECTIONS AND PERMITTED CLAIMS.
FOR USE IN MANUFACTURED FEEDS ONLY.
SPL UNCLASSIFIED SECTION
ACTIVE DRUG INGREDIENT: Fenbendazole 200 grams per kilogram (90.7 grams per pound).
INERT INGREDIENTS: Roughage Products or Roughage Products and Calcium Carbonate; and Mineral Oil.
VETERINARY INDICATIONS SECTION
CATTLE: Dairy and Beef Cattle
FOR THE TREATMENT AND CONTROL OF:
Lungworms: Adult Dictyocaulus viviparus; Stomach worms: Adult brown stomach worms (Ostertagia ostertagi), Adult and fourth stage larvae barberpole worms (Haemonchus contortus), fourth stage larvae barberpole worms (H. placei), and Adult and fourth stage larvae small stomach worms (Trichostrongylus axei); Intestinal worms (Adult and fourth stage larvae): hookworms (Bunostomum phlebotomum), thread-necked intestinal worms (Nematodirus helvetianus), small intestinal worms (Cooperia punctata & C. oncophora), bankrupt worms (Trichostrongylus colubriformis), and nodular worms (Oesophagostomum radiatum).
DRUG FEEDING RATE:
5 mg fenbendazole per kg body weight in a one (1) day treatment (2.27 mg fenbendazole per pound).
Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.
MIXING DIRECTIONS:
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated cattle feed according to the table below to obtain the proper concentration in the Type B medicated feed. The following table gives examples of how some Type B medicated feed concentrations can be prepared:
| Pounds of Type A Medicated Article to Add per Ton of Feed to Make a Type B Medicated Feed | Resulting Fenbendazole Concentration in Type B Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 11.04 | 1,001 (0.5) |
| 195.59 | 17,740 (8.9) |
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated cattle feed according to the table below to obtain the proper concentration in the complete Type C medicated feed. Prepare an intermediate pre-blend of the Type A medicated article prior to mixing in a complete feed. Thoroughly mix the required amount of Type A medicated article in a convenient quantity of feed ingredients (a dilution of one part Type A medicated article and nine parts grain carrier is suggested), then thoroughly mix this pre-blend with the rest of the feed ingredients to ensure complete and uniform distribution of the Type A medicated article.
The following table gives examples of how some complete Type C medicated feeds can be prepared:
| Pounds of Type A Medicated Article to Add per Ton to Make a Type C Medicated Feed | Resulting Fenbendazole Concentration in Type C Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 2.20 | 200 (0.1) |
| 11.02 | 1,000 (0.5) |
FEEDING DIRECTIONS:
Feed as the sole ration for one (1) day. No prior withdrawal of feed or water necessary. Type C medicated cattle feeds containing SAFE-GUARD® 20% can be fed pelleted or as a meal.
FREE-CHOICE FEEDS: Type C free-choice medicated feed must be manufactured by a licensed feed mill according to an approved formula to provide a total of 5 mg per kg body weight fenbendazole over 3 to 6 days.
WARNINGS SECTION
WARNING: KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. NOT FOR USE IN HUMANS. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or www.fda.gov/reportanimalae.
SPL UNCLASSIFIED SECTION
OTHER WARNINGS: Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug's effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.
RESIDUE WARNING SECTION
Withdrawal Periods and Residue Warnings: Milk taken during treatment and for 60 hours after the last treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 13 days following last treatment with this drug product. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves.
VETERINARY INDICATIONS SECTION
SWINE: Growing pigs, gilts, pregnant sows, and boars
FOR THE TREATMENT AND CONTROL OF:
Lungworms: Adult Metastrongylus apri, adult Metastrongylus pudendotectus; Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworms (Ascaris suum), Adult nodular worms (Oesophagostomum dentatum, O. quadrispinulatum), Adult small stomach worms (Hyostrongylus rubidus), Adult and larvae (L2, L3, L4 stages - intestinal mucosal forms), whipworms (Trichuris suis); and Kidney worms: Adult and larvae Stephanurus dentatus.
DRUG FEEDING RATE:
9 mg fenbendazole per kg body weight (4.08 mg fenbendazole per pound) to be fed as the sole ration over a period of 3 to 12 days.
MIXING DIRECTIONS:
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated swine feed according to the table below to obtain the proper concentration in the Type B medicated feed. The following table gives examples of how some Type B medicated feed concentrations can be prepared:
| Pounds of Type A Medicated Article to Add per Ton of Feed to Make a Type B Medicated Feed | Resulting Fenbendazole Concentration in Type B Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 11.03 | 1,000 (0.5) |
| 195.59 | 17,740 (8.9) |
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated swine feed according to the table below to obtain the proper concentration in the complete Type C medicated feed. Prepare an intermediate pre-blend of the Type A medicated article prior to mixing in a complete feed. Thoroughly mix the required amount of Type A medicated article in a convenient quantity of feed ingredients (a dilution of one part Type A medicated article and nine parts grain carrier is suggested), then thoroughly mix this pre-blend with the rest of the feed ingredients to ensure complete and uniform distribution of the Type A medicated article.
The following table gives examples of how some complete Type C medicated feeds can be prepared:
| Pounds of Type A Medicated Article to Add per Ton to Make a Type C Medicated Feed | Resulting Fenbendazole Concentration in Type C Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 0.11 | 10 (0.005) |
| 3.31 | 300 (0.15) |
FEEDING DIRECTIONS:
Feed as the sole ration for three (3) to twelve (12) consecutive days. No prior withdrawal of feed or water necessary.
Type C medicated swine feeds containing SAFE-GUARD® 20% can be fed pelleted or as a meal.
WARNINGS SECTION
WARNING: KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. NOT FOR USE IN HUMANS. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or www.fda.gov/reportanimalae.
SPL UNCLASSIFIED SECTION
OTHER WARNINGS: Parasite resistance may develop to any dewormer. All dewormers require accurate dosing for best results. Following the use of any dewormer, effectiveness of treatment should be monitored. A decrease of effectiveness over time may indicate the development of resistance to the dewormer administered. The parasite management plan should be adjusted accordingly based on regular monitoring.
SPL UNCLASSIFIED SECTION
Withdrawal Periods: Swine must not be slaughtered for human consumption within 4 days following last treatment with this drug product.
HORSES
FOR THE TREATMENT AND CONTROL OF:
Large strongyles (Strongylus edentatus, S. equinus, S. vulgaris, Triodontophorus spp.), Small strongyles (Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp.), Pinworms (Oxyuris equi), Ascarids (Parascaris equorum).
DRUG FEEDING RATE:
For the control of large strongyles, small strongyles, and pinworms the recommended dose is 5 mg fenbendazole per kg body weight (2.27 mg fenbendazole per pound) in a one (1) day treatment. For the control of ascarids the recommended dose is 10 mg fenbendazole per kg body weight (4.54 mg fenbendazole per pound) in a one (1) day treatment.
All horses must be eating normally to ensure that each animal consumes an adequate amount of the medicated feed.
Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.
MIXING DIRECTIONS:
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated horse feed according to the table below to obtain the proper concentration in the Type B medicated feed. The following table gives examples of how some Type B medicated feed concentrations can be prepared:
| Pounds of Type A Medicated Article to Add per Ton of Feed to Make a Type B Medicated Feed | Resulting Fenbendazole Concentration in Type B Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 110.25 | 10,000 (5.0) |
| 195.59 | 17,740 (8.9) |
Thoroughly mix SAFE-GUARD® Type A medicated article with equine feed according to the table below to obtain the proper concentration in the Type C medicated feed.
| Pounds of Type A Medicated Article to Add per Ton to Make a Type C Medicated Feed | Resulting Fenbendazole Concentration in Type C Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 50.05 | 4,540 (2.27) |
FEEDING DIRECTIONS:
No prior withdrawal of feed or water necessary. Type C medicated horse feed containing SAFE-GUARD® 20% can also be fed pelleted.
WARNINGS SECTION
WARNING: KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. NOT FOR USE IN HUMANS. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or www.fda.gov/reportanimalae.
RESIDUE WARNING SECTION
OTHER WARNINGS: Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug's effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.
Do not use in horses intended for human consumption.
SPL UNCLASSIFIED SECTION
Approved by FDA under NADA # 131-675
CONSULT YOUR VETERINARIAN FOR ASSISTANCE IN THE DIAGNOSIS, TREATMENT, AND CONTROL OF PARASITISM.
STORAGE AND HANDLING SECTION
STORE AT OR BELOW 25°C (77°F). EXCURSIONS UP TO 40°C (104°F) ARE PERMITTED.
SPL UNCLASSIFIED SECTION
SEE OTHER SIDE FOR ZOO AND WILDLIFE ANIMALS, GROWING TURKEYS AND WILD QUAIL.
Net Weight 25 pounds (11.34 kg)
Lot/Expiration date located below:
797217 R2
Zoo and Wildlife Animals
FOR THE TREATMENT AND CONTROL OF:
Internal parasites in hoofed zoo and wildlife animals (see dosage section for specific parasites, animal species and required doses).
DRUG FEEDING RATES:
| Host Animal | Recommended Treatment For | mg Fenbendazole/kg Body Wt./Day × Days of Treatment |
|---|---|---|
| Bighorn sheep (Ovis canadensis canadensis) | Lungworms: (Protostrongylus spp.) | 10 mg/kg/day × 3 days |
| Feral swine (Sus scrofa) | Kidney worms: (Stephanurus dentatus), Roundworms:(Ascaris suum), Nodular worms: (Oesophagostomum dentatum) | 3 mg/kg/day × 3 days |
| Ruminants – subfamily antilopinae: Persian gazelles (Gazella subgutturosa subgutturosa) Addra gazelle (Gazella dama ruficollis) Slendorhorn gazelle (Gazella leptoceros) Kenya impala (Aepyceros melampus rendilis) Roosevelt's gazelle (Gazella granti roosevelti) Indian blackbuck (Antilope cervicapra) Mhorr gazelle (Gazella dama mhorr) Thomson's gazelles (Gazella thomsoni thomsoni) Ruminants – subfamily hippotraginae: Addax (Addax nasomaculatus) Angolan roan antelope (Hippotragus equinus cottoni) Fringed-ear oryx (Oryx gazelle callotis) Arabian oryx (Oryx leucoryx) Ruminants – subfamily caprinae: Armenian mouflon (Ovis orientalis gmelini) Russian saiga (Saiga tatarica) | Small stomach worms: (Trichostrongylus spp.), Thread-necked intestinal worms: (Nematodirus spp.), Barberpole worms: (Haemonchus spp.), Whipworms: (Trichuris spp.) | 2.5 mg/kg/day × 3 days  |
 |
It is recommended that the user exercise judgmental expertise as needed for retreatment within six (6) weeks. This would depend upon the conditions of continued exposure to parasites, condition of treated animals, and ambient temperatures.
MIXING DIRECTIONS:
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated zoo/wildlife animal feed according to the table below to obtain the proper concentration in the complete Type C medicated feed. Prepare an intermediate pre-blend of the Type A medicated article prior to mixing in a complete feed. Thoroughly mix the required amount of Type A medicated article in a convenient quantity of feed ingredients (a dilution of one part Type A medicated article and nine parts grain carrier is suggested), then thoroughly mix this pre-blend with the rest of the feed ingredients to ensure complete and uniform distribution of the Type A medicated article.
The following table gives examples of how some complete Type C medicated feeds can be prepared:
| Pounds of Type A Medicated Article to Add per Ton to Make a Type C Medicated Feed | Resulting Fenbendazole Concentration in Type C Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 0.55 | 50 (0.025) |
| 11.02 | 1,000 (0.5) |
FEEDING DIRECTIONS:
Type C medicated feeds containing SAFE-GUARD® 20% can be fed in either a mash or pelleted form. No prior withdrawal of feed or water is necessary.
WARNINGS SECTION
WARNING: KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. NOT FOR USE IN HUMANS. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or www.fda.gov/reportanimalae.
SPL UNCLASSIFIED SECTION
OTHER WARNINGS: Parasite resistance may develop to any dewormer. All dewormers require accurate dosing for best results. Following the use of any dewormer, effectiveness of treatment should be monitored. A decrease of effectiveness over time may indicate the development of resistance to the dewormer administered. The parasite management plan should be adjusted accordingly based on regular monitoring.
RESIDUE WARNING SECTION
RESIDUE WARNING: Do not use 14 days before or during the hunting season.
Growing Turkeys
FOR THE TREATMENT AND CONTROL OF:
Gastrointestinal worms: Roundworms, Adults and larvae (Ascaridia dissimilis); Cecal worms, Adults and larvae (Heterakis gallinarum), an important vector of Histomonas meleagridis (Blackhead).
DRUG FEEDING RATE:
14.5 g fenbendazole/ton of feed, to be fed as the sole ration for 6 days.
MIXING DIRECTIONS:
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated turkey feed according to the table below to obtain the proper concentration in the Type B medicated feed. The following table gives an example of how some Type B medicated feed concentrations can be prepared:
| Pounds of Type A Medicated Article to Add per Ton of Feed to Make a Type B Medicated Feed | Resulting Fenbendazole Concentration in Type B Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 5.51 | 500 (0.25) |
| 195.59 | 17,740 (8.9) |
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated growing turkey feed according to the table below to obtain the proper concentration in the complete Type C medicated feed. Prepare an intermediate pre-blend of the Type A medicated article prior to mixing in a complete feed. Thoroughly mix the required amount of Type A medicated article in a convenient quantity of feed ingredients (a dilution of one part Type A medicated article and nine parts grain carrier is suggested), then thoroughly mix this pre-blend with the rest of the feed ingredients to ensure complete and uniform distribution of the Type A medicated article.
The following table describes how to obtain the proper concentration in the complete Type C medicated feed:
| Pounds of Type A Medicated Article to Add per Ton to Make a Type C Medicated Feed | Resulting Fenbendazole Concentration in Type C Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 0.16 | 14.5 (0.007) |
FEEDING DIRECTIONS:
Medicated feed containing fenbendazole should be fed as the sole ration for six (6) consecutive days to growing turkeys only. No prior withdrawal of feed or water necessary. Type C medicated growing turkey feeds containing SAFE-GUARD® 20% can be fed pelleted or as a meal.
WARNINGS SECTION
WARNING: KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. NOT FOR USE IN HUMANS. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or www.fda.gov/reportanimalae.
SPL UNCLASSIFIED SECTION
OTHER WARNINGS: Parasite resistance may develop to any dewormer. All dewormers require accurate dosing for best results. Following the use of any dewormer, effectiveness of treatment should be monitored. A decrease of effectiveness over time may indicate the development of resistance to the dewormer administered. The parasite management plan should be adjusted accordingly based on regular monitoring.
RESIDUE WARNING SECTION
Withdrawal Periods: No withdrawal period is required when used according to labeling.
Wild Quail
FOR THE TREATMENT AND CONTROL OF:
Gastrointestinal worms: Cecal worms, (Aulonocephalus spp.)
DRUG FEEDING RATE:
90.7 g fenbendazole/ton of feed, to be fed for 21 days.
MIXING DIRECTIONS:
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated Wild Quail feed according to the table below to obtain the proper concentration in the Type B medicated feed. The following table gives an example of how some Type B medications can be prepared:
| Pounds of Type A Medicated Article to Add per Ton of Feed to Make a Type B Medicated Feed | Resulting Fenbendazole Concentration in Type B Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 11.04 | 1,001 (0.50) |
| 195.59 | 17,740 (8.9) |
Thoroughly mix SAFE-GUARD® 20% Type A medicated article with non-medicated Wild Quail feed according to the table below to obtain the proper concentration in the complete Type C medicated feed. Prepare an intermediate pre-blend of the Type A medicated article prior to mixing in a complete feed. Thoroughly mix the required amount of Type A medicated article in a convenient quantity of feed ingredients (a dilution of one part Type A medicated article and nine parts grain carrier is suggested), then thoroughly mix this pre-blend with the rest of the feed ingredients to ensure complete and uniform distribution of the Type A medicated article.
The following table describes how to obtain the proper concentration in the complete Type C medicated feed:
| Pounds of Type A Medicated Article to Add per Ton to Make a Type C Medicated Feed | Resulting Fenbendazole Concentration in Type C Medicated Feed [grams/ton (grams/pound)] |
|---|---|
| 1.0 | 90.7 (0.05) |
FEEDING DIRECTIONS:
Medicated feed should be fed for 21 consecutive days to wild quail. No prior withdrawal of feed is necessary. It is recommended that wild quail feed containing SAFE-GUARD® be fed as crumbles. It is not recommended that medicated feed containing fenbendazole be generally broadcast, but rather offered in strategic feeding stations or through feeders. Users should ensure that the medicated feed is consistently available during the 21-day treatment period.
WARNINGS SECTION
WARNING: KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. NOT FOR USE IN HUMANS. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800-211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or www.fda.gov/reportanimalae.
SPL UNCLASSIFIED SECTION
OTHER WARNINGS: Parasite resistance may develop to any dewormer. All dewormers require accurate dosing for best results. Following the use of any dewormer, effectiveness of treatment should be monitored. A decrease of effectiveness over time may indicate the development of resistance to the dewormer administered. The parasite management plan should be adjusted accordingly based on regular monitoring.
RESIDUE WARNING SECTION
Withdrawal Periods: No withdrawal period is required when used according to labeling.
SPL UNCLASSIFIED SECTION
CONSULT YOUR VETERINARIAN FOR ASSISTANCE IN THE DIAGNOSIS TREATMENT AND CONTROL OF PARASITISM.
STORAGE AND HANDLING SECTION
STORE AT OR BELOW 25°C (77°F). EXCURSIONS UP TO 40°C (104°F) ARE PERMITTED.
SPL UNCLASSIFIED SECTION
SEE OTHER SIDE FOR CATTLE, SWINE, AND HORSES.
Net Weight 25 pounds (11.34 kg)
SPL UNCLASSIFIED SECTION
Approved by FDA under NADA # 131-675
MERCK
Animal Health
Distributed by:
Intervet Inc. (d/b/a Merck Animal Health)
Rahway, NJ 07065
Copyright © 2023 Merck & Co., Inc., Rahway, NJ, USA
and its affiliates. All rights reserved.
Rev. 10/2023
PRINCIPAL DISPLAY PANEL - 11.34 kg Bag Label
TO OPEN-PULL NARROW TAPE
safe-guard®
(fenbendazole)
Dewormer
20% Type A
Medicated Article
CATTLE: Dairy and Beef Cattle
SWINE: Growing pigs, gilts, pregnant sows and boars
HORSES
Zoo and Wildlife Animals
Growing Turkeys
Wild Quail
MUST BE MIXED BEFORE FEEDING ACCORDING TO DIRECTIONS AND PERMITTED CLAIMS.
FOR USE IN MANUFACTURED FEEDS ONLY.
ACTIVE DRUG INGREDIENT: Fenbendazole 200 grams per kilogram (90.7 grams per pound).
INERT INGREDIENTS: Roughage Products or Roughage Products and Calcium Carbonate; and Mineral Oil.
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57926-090-25 | Safe-Guard | 11.34 kg in 1 BAG | POWDER | 11.34 | 5 | |
| 57926-090-25 | Safe-Guard | 1 in 1 BAG | POWDER | 1 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Fenbendazole | ACTIVE INGREDIENT | 621BVT9M36 | 1 | |
| Fenbendazole | ACTIVE MOIETY | 621BVT9M36 | 1 | |
| Calcium Carbonate | INACTIVE INGREDIENT | H0G9379FGK | 1 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 1 |
Products#
Every source-derived product name is available through these pages.
- Safe-Guard
- Fenbendazole
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57926-090 | 57926-090-25 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FENBENDAZOLE | 621BVT9M36 | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | GUM, CHEWING / BUCCAL | 3492 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | CAPSULE, DELAYED RELEASE / ORAL | 20 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, DELAYED RELEASE / ORAL | 8.4 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | FILM, SOLUBLE / ORAL | 14 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | CAPSULE / ORAL | 349.9 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, FILM COATED / ORAL | 300 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, EXTENDED RELEASE / ORAL | 229.7 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | CAPSULE, EXTENDED RELEASE / ORAL | 4 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / AURICULAR (OTIC) | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, CHEWABLE / ORAL | 1650 mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | POWDER, DENTIFRICE / DENTAL | 0.5 mg/mg | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET / ORAL | 793 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | SOLUTION / INTRAVENOUS | 4.02 %w/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | SOLUTION / RESPIRATORY (INHALATION) | 4.02 %w/v | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | SOLUTION / AURICULAR (OTIC) | 0.38 %w/w | ||
| Calcium Carbonate | CALCIUM CARBONATE | H0G9379FGK | TABLET, COATED / ORAL | 64.8 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.